Arsenic trioxide with ascorbic acid and high-dose melphalan: A new preparative regimen for autologous hematopoietic stem cell transplantation for multiple myeloma.

被引：0
|
作者：
Qazilbash, MH [1 ]
Davis, MS [1 ]
Ana, A [1 ]
Roden, L [1 ]
Libunao, F [1 ]
Tball, PF [1 ]
Wang, XM [1 ]
Couriel, D [1 ]
De Lima, M [1 ]
Hosing, C [1 ]
Kebriaei, P [1 ]
Weber, D [1 ]
Wang, M [1 ]
Jones, RB [1 ]
Matthes, SG [1 ]
Champlin, RE [1 ]
Giralt, SA [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1159
引用
收藏
页码：338A / 339A
页数：2
相关论文
共 50 条
  • [41] Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
    Zver, Samo
    Zadnik, Vesna
    Cernelc, Peter
    Kozelj, Mitra
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 227 - 236
  • [42] Autologous stem cell transplantation with high dose melphalan conditioning regimen is safe for elderly multiple myeloma patients
    Czyz, Anna
    Szeremet, Agnieszka
    Bogucka-Fedorczuk, Aleksandra
    Majcherek, Maciej
    Rybka, Justyna
    Prajs, Iwona
    Wrobel, Tomasz
    BONE MARROW TRANSPLANTATION, 2019, 54 : 499 - 500
  • [43] Bortezomib after high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with multiple myeloma: A comparison with the historical conditioning regimen with melphalan alone
    Ferini, G. A.
    Arbelbide, J. A.
    Basquiera, A. L.
    Nucifora, E.
    Schutz, N.
    Otero, V.
    Fantl, D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S461 - S462
  • [44] Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma
    Hagen, Patrick
    Norton, Joseph
    Tsai, Stephanie
    Campo, Loredana
    Lee, Mary
    Gomez, Kayeromi
    Stiff, Patrick
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1422 - 1428
  • [45] The efficacy of high-dose melphalan with autologous peripheral blood stem cell transplantation in patients with multiple myeloma
    Lee, JL
    Kim, SB
    Lee, GW
    Ryu, MH
    Kim, E
    Kim, S
    Kim, WK
    Lee, JS
    Kim, SH
    Suh, C
    YONSEI MEDICAL JOURNAL, 2003, 44 (05) : 800 - 810
  • [46] Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma
    Olin, RL
    Luger, SM
    Porter, DL
    Schuster, SJ
    Tsai, D
    Nasta, S
    Perl, A
    Loren, AW
    Goldstein, S
    Mangan, P
    Sherry, V
    Cunningham, K
    Sachs, B
    Hummel, K
    Stadtmauer, EA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 87 - 87
  • [47] High-dose melphalan and autologous stem cell transplantation followed by non-myeloablative conditioning regime and allogeneic stem cell transplantation as consolidation therapy in multiple Myeloma.
    Schneider, P
    Fenk, R
    Bernhardt, A
    Rohr, U
    Till, E
    Wehmeier, A
    Haas, R
    Kobbe, G
    BLOOD, 2001, 98 (11) : 351B - 351B
  • [48] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A UNIVERSITARY HOSPITAL
    Dunia, D. M.
    Dolores, M.
    Dolores, S.
    Nuria, G.
    Miguel, D.
    Jaime, A.
    Helga, G.
    Alejandro, V.
    Sonia, H.
    Blanca, P.
    HAEMATOLOGICA, 2016, 101 : 862 - 862
  • [49] Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen
    Hagen, Patrick
    D'Souza, Anita
    Hari, Parameswaran
    Davila, Omar
    Zhang, Mei-Jie
    Vesole, David H.
    Smith, Scott E.
    Rodriguez, Tulio E.
    Stiff, Patrick J.
    BLOOD, 2019, 134
  • [50] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A UNIVERSITARY HOSPITAL
    de Miguel, D.
    Morales, D.
    San Roman, I.
    Golbano, N.
    Diaz, M.
    Arbeteta, J.
    Herrero, S.
    Subira, D.
    PInedo, B.
    HAEMATOLOGICA, 2012, 97 : 622 - 622
12345